MedPath

Effects of Inspiratory Muscle Training on Blood Pressure Levels in Hypertensive Individuals

Not Applicable
Conditions
Hypertension
Registration Number
NCT02275377
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

This research aims to evaluate the effects of inspiratory muscle training (IMT) on blood pressure, in inspiratory muscle mechanoreflex, autonomic cardiovascular control in subjects with hypertension.

Detailed Description

Patients with hypertension will be selected through the Outpatient Hypertension of the Hospital of Clinics de Porto Alegre, for convenience. Subsequently, patients will be subjected to test respiratory muscle strength (manometer), respiratory muscle resistance, cardiopulmonary exercise testing (maximum), evaluation of cardiac reflex sensitivity and autonomic control test and induction of inspiratory muscle mechanoreflex with occlusion plethysmography at baseline before the start of the training protocol. Patients will randomize inspiratory muscle training for 30 minutes a day, 7 days a week, for 8 weeks with muscle training device (PowerBreathe). There will be a weekly monitoring in the Clinical Research Center of the institution where the maximal inspiratory pressure (MIP) and respiratory training techniques will be reassessed and readjusted (40% of MIP). The control group will be submitted to respiratory training techniques with muscle training device (PowerBreathe) without load. After this period, all initial tests will be reassessed. A healthy control group study with 10 normotensive individuals will be included.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

Participants will be selected from the medical records in search of Basic Health Unit and Hypertension Clinic - Hospital of Clinics of Porto Alegre (HCPA), Porto Alegre - RS:

  • Diagnosis of essential hypertension with systolic blood pressure ≥140 mmHg and / or diastolic blood pressure ≥ 90 mmHg without treatment or use of antihypertensive;

  • Only taking diuretics (monotherapy) or none;

  • Body mass index ≤ 29.9 kg / m²;

  • Not engaged in physical activity;

  • Inspiratory muscle strength ≥ 70% of predicted.

    • Inclusion of normotensive individuals with systolic blood pressure <130 mmHg and/or diastolic blood pressure <85 mmHg by ambulatory blood pressure monitoring (ABPM).
Exclusion Criteria
  • Blood pressure ≥ 160/100 mmHg
  • Pregnant and lactating women;
  • Deep vein thrombosis; current or previous.
  • Diabetes mellitus;
  • Orthopedic impairments, musculoskeletal, neurological and / or cognitive impairment, or even other diseases that compromise participation in the proposed protocol;
  • Acute myocardial infarction within the last 6 months;
  • Hearth failure;
  • Angina pectoris;
  • Pulmonary impairment from any source;
  • Current smoking.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Levels of blood pressure (mmHg)8 weeks

Ambulatory blood pressure monitoring (ABPM).

Secondary Outcome Measures
NameTimeMethod
Inspiratory muscle mechanoreflex8 weeks

Venous occlusion plethysmography measure during inspiratory muscle training exercise at 60% and 2% of maximal inspiratory muscle strength.

Cardiopulmonary Capacity8 weeks

High-intensity exercise test (maximum) assessed by ergometry with noninvasive hemodynamic monitoring (electrocardiogram, exhaled gas analyzer, heart rate, respiratory rate and blood pressure).

Autonomic cardiovascular control8 weeks

Heart rate and blood pressure monitoring in the time domain (spectral analysis).

Trial Locations

Locations (1)

Leila Moreira

🇧🇷

Porto Alegre, Rio Grande do Sul, Brazil

Leila Moreira
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Leila B Moreira, PhD
Contact
+55 51 33597695
lbmoreira@hcpa.ufrgs.br
Simone R Posser, Msc
Contact
+55 54 84096027
sposser@hcpa.ufrgs.br

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.